Instructions for authors are shaped on the recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/).

The ethics of The New Journal of Urology have been established in accordance with the guidelines of Committee on Publication Ethics (COPE) (https://doi.org/10.24318/cope.2019.2.24).

The Editorial Board follows to the recommendations of International Committee of Medical Journal Editors (ICJME) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.

Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.

An approval of research protocols by the Ethics Committee in accordance with international agreements World Medical Association Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) is required for experimental, clinical, and drug studies and for some case reports.

If required, ethics committee reports or an equivalent official document will be requested from the authors.

If there is any concern or dispute at over the studies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.. https://doi.org/10.24318/cope.2019.2.26

 

A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence the author's decisions or work on the manuscript. Authors are required to identify all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, stock ownership or options, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests that represent potential future financial gain. The disclosure of funding should be indicated in the Acknowledgments section within the manuscript.

The “Copyright Agreement and Acknowledgement of Authorship Form” should be completed by the corresponding author on behalf of each coauthor and should be submitted with the manuscript.

The Editorial Board of The New Journal of Urology will immediately reject a submitting manuscript which has a high similarity index to other papers in the Similarity Check (iThenticate). When malpractices are found in the submitted article to The New Journal of Urology, Editorial Board will follow the flowchart by the Committee on Publication Ethics (COPE) for settlement of any misconduct. The Editorial Board of The New Journal of Urology is always willing to publish corrections, clarifications, retractions when needed.

The New Journal of Urolgy requires each submission to be accompanied by Copyright Agreement and Acknowledgement of Authorship Form. When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).

• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo.

• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.

• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.

• It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.

All submissions are screened by a similarity detection software (iThenticate) and the limitation without similarity is 20%.

Statements or opinions expressed in the manuscripts published in The New Journal of Urology reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility in regard to the published content rests with the authors.

The Editorial Board of the journal handles all appeal and complaint cases within the scope of Committee on Publication Ethics guidelines (COPE). In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor-in-Chief is the final authority in the decision-making process for all appeals and complaints.

 

The New Journal of Urology follows the principles of transparency and best practices for scholarly publishing as identified by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME).

Archiving
To secure the durability and availability of the published material (publisher's version/PDF), articles are systematically archived in multiple reliable repositories, including:
Publisher’s Archive: All articles are stored in the official archives of The New Journal of Urology for long-term access.
Crossref: Articles are registered with unique Digital Object Identifiers (DOIs), ensuring their discoverability and permanence in digital environments.
Institutional Repositories: Authors are encouraged to deposit the final published version of their articles in their affiliated institutional repositories.
Author’s Personal Websites: Authors may archive their work on personal or professional websites, enhancing the visibility of their research.

Distribution
Authors are free to share and distribute their articles, provided the original source is properly acknowledged. Key guidelines for distribution include:
Citation Standards: When sharing or redistributing their work, authors and readers must provide accurate citations, including the DOI link to the publisher’s version. This practice ensures proper credit and academic integrity.
Self-Archiving: Authors are encouraged to self-archive their articles on platforms such as institutional repositories, social media, or academic networking sites, provided the publisher’s final version is used for reference.
Open Access Availability: All articles are published under the Creative Commons CC BY Attribution 4.0 International License, allowing unrestricted sharing, adaptation, and reuse, provided appropriate credit is given to the original authors and source.

By adopting these practices, The New Journal of Urology ensures that your research remains widely accessible, discoverable, and preserved for future generations of scholars and practitioners.

 

The New Journal of Urolgy requires each submission to be accompanied by a Copyrıght Agreement and Acknowledgement of Authorship Form.

All of the authors have to confirm the originality of the study and their own contribution to the study.

When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).

The contents can be used as a reference in scientific publications and presentations.

The New Journal of Urology allows the author to retain copyright without restriction.

There is no charge for publishing, or no copyright fee is paid to the authors.

No fee is required for submitting articles, evaluation, processing or publishing process from the authors.

All published content in The New Journal of Urology are licensed under Creative Commons Attribution CC-BY 4.0 International License. Authors consent to publication of their work by The New Journal of Urology under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Under this licence, the third parties and authors are free to copy, distribute, transmit, adapt, and even make commercial use of the material, provided the article is properly cited.

Provided that the original author(s) and citation details are acknowledged, the authors grant any third party the right to use the article freely.
Authors grant this journal permission to publish the article and to identify itself as the original publisher.

The manuscript should be cited using the DOI, as provided by the journal.
The authors have confirmed their contribution to this work and have read and signed the conflict of interest declaration. Authors warrant that they have approved and are responsible for the article or any material contained therein.
The authors must ensure that the study under consideration is original and does not contain plagiarized content. The content in question must be original and not otherwise under copyright elsewhere (in whole or in part).
The authors warrant that the contribution or any material contained therein has not been published previously and will not be submitted for publication elsewhere.
The authors must avoid duplicate publication, which is reproducing verbatim content from their other publications.
The authors retain copyright without restriction.
All commercial rights associated with the contribution are retained by the contributors.
Nothing in this licence should be construed as impinging on the author's right to maintain the integrity and ownership of his or her work or as detracting from or restricting it.

If there is any concern or dispute at over the studies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.

https://doi.org/10.24318/cope.2019.2.26

Authors are required to confirm that their submitted work is original and has not been published or submitted elsewhere in any form. All manuscripts undergo a rigorous plagiarism check using iThenticate, a widely recognized tool for detecting text similarities in academic publications (excluding abstracts and reference sections). Submissions with a similarity rate exceeding 20% may be rejected or returned for revision at the discretion of the editorial board.
In cases of significant overlap with previously published material, the editorial team follows the guidelines of the Committee on Publication Ethics (COPE) to evaluate and address potential breaches of ethical standards. While limited text recycling may be permissible in specific manuscript sections—such as methods or introductions—authors must avoid unnecessary duplication and explicitly cite any reused material.
The duplication of results, figures, or tables without proper attribution or justification is strictly prohibited. Any reuse of content must be transparent, appropriately attributed, and in compliance with copyright regulations.
If suspected plagiarism is found in an article either before (by reviewers or editorial team) or after (by readers) publication, the journal will act according to COPE’s code of conduct and flowcharts.
COPE guidelines: COPE Council. All flowcharts. https://doi.org/10.24318/cope.2019.2.26

Retraction Policy

A published article may be retracted if it is determined that:
•    The data or findings are significantly unreliable due to errors, miscalculations, or experimental flaws.
•    Ethical violations have occurred, such as data fabrication, falsification, or plagiarism.
•    There is evidence of undeclared conflicts of interest or unauthorized use of copyrighted material.
•    The research breaches ethical standards involving human or animal subjects.

Retractions are issued to alert readers to major issues while preserving the integrity of the scientific record. Retraction notices will clearly state:
•    The title and authors of the retracted article.
•    The reason(s) for the retraction, including any supporting evidence.
•    A statement clarifying whether the error was unintentional or due to misconduct.

Retraction notices will remain permanently linked to the original article's DOI and will be freely accessible to readers. The original article will not be removed but will be clearly marked as retracted.

Correction Policy

In cases where the article’s findings remain reliable, but minor errors or inaccuracies are identified, a correction will be issued instead of a retraction. Examples include:
•    Typographical errors or formatting mistakes that do not affect the interpretation of data.
•    Errors in author affiliations or funding acknowledgments.
•    Inaccuracies in references or minor methodological descriptions.

Corrections will follow a thorough review by the editorial team to ensure they address the issue without compromising the article's validity. A correction notice will include:
•    A clear description of the error.
•    The corrected content.
•    A reference to the original article’s DOI.

Procedure for Retraction or Correction

The retraction or correction process may be initiated by authors, readers, or the editorial team. Requests must be submitted to the editorial office with supporting evidence of the issue. Each case will be carefully reviewed by the editor-in-chief and, where necessary, external experts to ensure an impartial decision.
It is imperative to emphasise that, in all circumstances, the Editor is obligated to adhere to the guidelines stipulated by the Committee on Publication Ethics (COPE) with regard to retraction and correction. This commitment ensures that any decision pertaining to such matters is made with utmost transparency and in strict accordance with the most efficacious practices.

COPE Council. COPE Guidelines: Retraction Guidelines. November 2019. 
https://doi.org/10.24318/cope.2019.1.4

Nowadays, the use of artificial intelligence in the writing of original research articles is becoming widespread thanks to the developing technological conditions. The author is obliged to follow the ethical standards regarding the use of artificial intelligence in the writing of articles submitted to the New Journal of Urology. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. This may constitute standard plagiarism as the use of AI does not meet the criteria for authorship.

Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author, or be cited as an author. The editors and reviewers of the New Journal of Urology are careful to evaluate the text in terms of the use of artificial intelligence tools that can generate references.

Authors should disclose in their manuscript the use of AI and AI-assisted technologies in the writing process. A statement should appear in the published work. Please note that authors are ultimately responsible and accountable for the contents of the work.